PAWC
CASC

P.A.W. Capital’s Cascadian Therapeutics, Inc. CASC Stock Holding History

P.A.W. Capital’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
2017
Q4 		$740K Sell
2017
Q3 		$982K Buy